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Summary Introduction
Congenital contractural arachnodactyly (MIMCongenital contractural arachnodactyly (CCA) is an au-
121050), also known as ‘‘Beals syndrome,’’ is an autoso-tosomal dominant disorder that is phenotypically simi-
mal dominant disorder that has some of the phenotypiclar to but genetically distinct from Marfan syndrome.
characteristics of Marfan syndrome. The cardinal fea-Genetic-linkage analysis has implicated the ﬁbrillin-2
tures of CCA are multiple congenital contractures, cam-gene (FBN2) as the CCA locus. Mutation analysis of
ptodactyly, arachnodactyly, kyphoscoliosis, muscle hy-two isolated CCA patients revealed missense mutations,
poplasia, and external ear malformation (Beals andindicating that defects in FBN2 may be responsible for
Hecht 1971; Hecht and Beals 1972; Ramos-Arroyo etthis disorder. However, cosegregation of a mutant allele
al. 1985; McKusick 1994). However, as in Marfan syn-with the disease phenotype has not yet been established.
drome, there is signiﬁcant phenotypic variability withinWe have investigated the primary cause of CCA in a
and between families. Dolichostenomelia, micrognathia,large well-characterized kindred with ﬁve generations
and subluxation of the patella are among the featurescomprising 18 affected individuals. Previous studies
occasionally present (Hecht and Beals 1972; Ramos-demonstrated linkage of this family’s CCA phenotype
Arroyo et al. 1985; Viljoen 1994). The most severelyto FBN2. Mutation analysis of cDNA derived from the
affected CCA patients also may manifest cardiac abnor-proband and her affected brother, using a nonisotopic
malities including mitral valve prolapse, atrial septal de-RNase cleavage assay, revealed the partial skipping of
fect, ventricular septal defect, and aortic hypoplasia (An-exon 31. Approximately 25% mutant transcript is pro-
derson et al. 1984; Ramos-Arroyo et al. 1985).duced, which is apparently sufﬁcient to cause a CCA
There is sufﬁcient phenotypic similarity betweenMarfanphenotype. Sequence analysis of genomic DNA revealed
syndrome and CCA that, until the cloning and character-an unusual base composition for intron 30 and identiﬁed
ization of the ﬁbrillin genes (FBN1 and FBN2), there wasthe mutation, a g-26t transversion, in the vicinity of the
some speculation that the two disorders might be allelic.
splicing branch-point site in intron 30. Genomic DNA Since then, extensive studies have demonstrated that Mar-
from 30 additional family members, both affected and fan syndrome is due to a variety of mutations in FBN1
unaffected, then was analyzed for the mutation. The (Ramirez 1996), whereas CCA has been linked to the
results clearly demonstrate cosegregation of the branch- FBN2 locus (Lee et al. 1991; Tsipouras et al. 1992). To
point mutation with the CCA phenotype. This is the date, two missense mutations have been reported in ﬁbro-
ﬁrst report of a CCA mutation in a multiplex family, blast-cell strains derived from two isolated patients with
unequivocally establishing that mutations in FBN2 are CCA (Putnam et al. 1995), and a splicing defect has been
responsible for the CCA phenotype. In addition, branch- characterized in an affected mother and child (Wang et al.
point mutations only very rarely have been associated 1996). Together these data indicate that defects in FBN2
with human disease, suggesting that the unusual compo- are indeed responsible for CCA. However, signiﬁcant cose-
sition of this intron inﬂuences splicing stability. gregation of the CCA phenotype with any mutation has
not yet been shown. Here we report the identiﬁcation of
a branch-point mutation associated with the in-frame skip-
ping of exon 31 in a large well-characterized kindred with
CCA and show the segregation of this mutation with theReceived November 4, 1996; accepted for publication March 5,
1997. CCA phenotype.
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Figure 1 Pedigree of family S showing phenotypes, severity of the disorder and genotypes. /// Å Homozygous wild type; //0 Å
heterozygous, wild type, and mutant (g-26t). Blackened squares and circles denote affected males and females, respectively; a diagonal slash
through a symbol indicates that the individual is deceased. Severity scores are indicated as follows: * Å mild; ** Å moderate; *** Å severe;
and **** Å very severe. All 11 living affected individuals were examined (by B.S. and M.R.). Descriptions of deceased individuals and
assessments of their disease severity were provided by a family member (II-4) who is best informed about the family. Her anecdotal accounts
were well supported by photographic documentation and corresponded well with our clinical assessment of living family members. I-1 was
the ﬁrst child born to healthy, young, nonconsanguineous parents; he had severe kyphoscoliosis, a pectus excavatum, and a height of Ç143
cm. He died at age 44 years. His three siblings were not affected. II-1 died at age Ç70 years, from cardiac insufﬁciency. II-2 died at age 3 wk,
from unknown cause. II-3 died at age 63 years, from carcinoma. III-7 died at age 24 years, from eclampsia. III-15 was born after 28 wk
gestation and died soon thereafter; according to his mother he presented with characteristic contractures. IV-7 died soon after birth, together
with her mother (III-7).
of 26 family members from generations II–V (ﬁg. 1). conditions listed in table 2. This procedure produces
13 PCR fragments ofÇ750 bp each, with a T7 consen-Previously, this family had been included in a linkage
study using markers for FBN1 and FBN2 (Lee et al. sus promoter sequence added to the 5 end of the sense
strand and with a SP6 consensus promoter sequence1991). Eleven affected members were positively linked
to the FBN2 locus, with a LOD score of 2.281 (for theta added to the 5 end of the antisense strand. Addition
of the T7 and SP6 consensus promoter sequences toÅ 0) (Velinov et al. 1992). All family members were
interviewed and examined by use of a standardized pro- the second-round PCR products facilitates strand-spe-
ciﬁc in vitro transcription of cRNA from the PCR-tocol. Physical measurements were taken, and EDTA
blood was obtained from every individual. In addition, ampliﬁed template. NIRCA then was performed with
Mismatch Detect II (Ambion), according to the manu-4-mm punch biopsies were taken from the skin of the
forearm in affected individuals IV-8 and IV-9 to estab- facturer’s instructions.
lish ﬁbroblast cultures. This study was done with the
DNA Sequence Analysisinformed consent of the subjects.
PCR-ampliﬁed DNA fragments (cDNA and genomic)
Nonisotopic RNase Cleavage Assay (NIRCA) were isolated from low-melting-temperature agarose, by
use of an Ultrafree-MC spin column (Millipore). TheNIRCA was performed on cDNA prepared from
cultured skin ﬁbroblasts isolated from patient IV-8 isolated cDNA was treated with Klenow polymerase to
ensure full extension of the product (Ausubel et al.and an unrelated normal control. Isolation of mRNA
and subsequent preparation of total cDNA was done 1995). A second round of PCR ampliﬁcation was done
under the same conditions, with either a biotinylatedby use of standard techniques (Ausubel et al. 1995).
First-round PCR ampliﬁcation of the cDNA was done sense or a biotinylated antisense primer. Single-stranded
DNA was isolated by use of streptavadin-coated mag-by use of the primers and conditions listed in table 1.
This procedure ampliﬁes the entire coding region of netic beads, according to the manufacturer’s (Dynal)
protocol. Solid-phase DNA sequencing was done withﬁbrillin-2, as seven fragments of Ç1.5 kb each. A sec-
ond round of ampliﬁcation was done by use of the nested sequencing primers, by use of the Fidelity Se-
quencing system (Oncor).ﬁrst-round products as template, with the primers and
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Table 1
PCR Primers Used to Amplify Coding Region of FBN2 in Seven Overlapping Fragments
Sense Primerb Antisense Primer
Fragment Positiona (5–3 ) (5–3 )
1 136–1495 ACAGGTTCGGTCCGCTACAGC GCTTACAGATATCTATTGTCTGGTTC
2 1330–2889 AGTGGCAATGGCAATGGCTATGG GCCAGGGAACACCTCACACTCAT
3 2687–4228 CTGTTGGCTCAACATCCAGGAC CGTCCAGATCAATACACTTGATGC
4 4088–5602 GATGTACAGATGTGGATGAGTGTG TGATGCAGTCTGCATTCCGCTG
5 5464–6963 GTGTGCATTAACCAGATTGGCAGT GATGCACATGAAGGTGCCGATTAG
6 6817–8302 TCCTATGAATGCACGTGCCCGAT CGTTGATTTTGCACTCGTAGCATG
7 8114–9645 GCAATTACGGCTGCTCTAACACG TCAGCTGCCTACAGTACCATGAG
NOTE.—The PCR reaction conditions are with standard buffer conditions (Perkin Elmer Cetus) at 94C for 1 min and 68C for 3 min, for
30 cycles.
a cDNA nucleotide positions encompassed by the ampliﬁed fragment; numbering is according to Zhang et al. (1994).
b Primers 5 to sense primer 1 have not ampliﬁed cDNA in our hands.
Allele-Speciﬁc PCR consistently produced two bands, corresponding to the
normal transcript and the aberrantly spliced transcript.Presence of the mutant allele was determined in a
The reactions were done three times each on three differ-blind study of genomic DNA from family members, by
ent RNA isolates, with indistinguishable results. Theuse of allele-speciﬁc PCR (Bottema et al. 1993). Geno-
band intensities were determined by densitometry, andmic DNA was ampliﬁed differentially by use of primers
the percentage of each transcript species was calculatedthat represent the normal sequence encompassing the
on the basis of the relative signal of each band in a given026 position of intron 30 and the mutant sequence at
reaction.that position (5-ACTGTGATGAGCACATACTA-3
and 5-ACTGTGATGAGCACATACGA-3, wild type
and mutant, respectively). A second invariant PCR Results
primer downstream from that site (in exon 32) was used
Clinical Presentation of Affected Members of Family Sas the primer pair (5-TCGCAGTTATGAGCACCAAT-
The details of the clinical examination are summa-3). Characterization of this assay demonstrated that
rized in table 3 and in selected patient photographsthe wild-type intron 30 primer ampliﬁed genomic DNA
shown in ﬁgure 2. Affected individuals could be identi-from both the patient and normal controls, whereas the
ﬁed immediately by their mothers at birth, on the basismutant primer was capable of amplifying only genomic
of the individuals’ hands, which were in clenched (ﬁst-DNA from the affected individual in whom the mutation
like) positions, and on the basis of their ears, whichhad been characterized. The ampliﬁcations were done
unequivocally were described as resembling ‘‘cabbageby use of standard buffer conditions (Perkin Elmer
leaves.’’ The auricular deformity resolved with age andCetus) at 94C for 1 min and at 69C for 3 min, for 40
was appreciable only in the youngest family member,cycles, with a ﬁnal extension at 72C for 7 min. The
IV-5, in whom we could conﬁrm the palpatory impres-products were visualized by standard ethidium bro-
sion of a cabbage leaf. This ﬁnding was, however, incon-mide–agarose gel electrophoresis. In all cases the prim-
spicuous to us in all adults. Camptodactyly also im-ers gave a single band of the expected size, 1.8 kb.
proved with age, but it remained the leading phenotypic
Analysis of Frequency of Exon Skipping feature. Contractures of larger joints were present in
varying degrees in all affected individuals. Kyphoscolio-The cDNAs derived from patients IV-8 and IV-9 were
analyzed to estimate the frequency of the skipping of sis, thoracic deformities, and muscular hypoplasia of
calves and forearms were observed in all affected indi-exon 31. Patient cDNA was PCR ampliﬁed by use of
primer pair 3/2 (table 2), in separate reactions of 18, viduals. In addition, all affected individuals presented
with dolichostenomelia and arachnodactyly.Most of the20, 22, and 24 cycles, in the presence of 2.5 mCi
32PadCTP under the conditions speciﬁed in table 2, with arm spans signiﬁcantly exceeded the body height but,
because of contractures of elbows and ﬁngers, are under-the exception of the addition of 5% dimethylsulfoxide
to the reaction to reduce any possibility of mispriming estimated as given in table 3. The same held true for
assessment of the lower-body segment, as a result ofdue to formation of secondary structures. Ten microli-
ters of each reaction was electrophoresed on a 1% agar- contractures of the knee. A feature present only in fe-
male affected family members was a marked truncalose gel. The DNA was ﬁxed with 8% acetic acid, and
the gel was dried and autoradiographed. Each reaction adipositas, which contrasted with the long and slender
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Figure 2 Phenotypic characteristics in family S. a, Family members
IV-5 and IV-6, who are DZ twins. Only IV-5 (left side, in all views) is
affected and has the skeletal manifestations of CCA with a moderate pheno-
type, when compared with other affected family members. Note the dolicho-
stenomelia, arachnodactyly, chest deformity, hypoplastic calf muscles, and
elevation of the patella. b, Hands of II-4 (bottom) and III-12 (top). Note
that IV-5, II-4, and III-12 have severe contractures of the ﬁngers and campto-
dactyly of the 5th ﬁnger (III-12). c, Comparison of ear deformity in IV-5
(left) with the normal ear of his twin, IV-6 (right).
limbs. Members III-6 and III-13 had undergone surgery athrosis in II-4, and a cleft soft palate and uvula biﬁda
in III-9.for habitual patella luxation, and we also observed ele-
vated and hypermobile patellae in IV-5.
Natural History/Clinical Course of CCA in Family SThe skin of most of the affected family members was
noted to be ﬁne and thin, and supragluteal striae were The particularly marked ﬁnger contractures obviously
did not lead to major handicaps in adulthood. Thenoted in individuals II-6, III-13, and IV-9. No cardiovas-
cular abnormalities were either noted or detected in any grandmothers in this family worked as tailor (II-4) and
waitress (II-6), lifting large and heavy trays. All othersof the affected family members. Individuals III-6 and III-
9 recently had undergone echocardiography because of in the following generation chose professions regardless
of their contractures. However, it should be noted thatsuspected Marfan syndrome. No abnormalities were
found; in particular, there was no dilatation of the aortic II-4, III-9, IV-5, and IV-9 had undergone surgery for
ﬁnger and ankle contractures, without apparent success.root or of the sinus valsavae. II-4 had a history of epi-
sodes of supraventricular arrhythmia, which did not re- Individuals III-3, III-6, III-9, and III-12 have chosen not
to have children.quire therapy; we noted a soft mesosystolic murmur.
Regarding the ocular system, there was no history or
NIRCA and DNA Sequence Analysisclinical sign of lens dislocation or retinal detachment.
Only two individuals were myopic, one of them (III-4) Analysis of cRNA derived from patient IV-8, covering
the coding region of FBN2, revealed a single aberrantto a high degree. II-6 had undergone surgery for a cata-
ract, III-3 for keratoconus. Additional features were a signal in fragment 3/2, indicating a sequence different
from the normal control cRNA. All other fragments hadhearing deﬁcit since childhood in II-6, varicosis and cox-
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Figure 3 a, PCR ampliﬁcation of cDNA derived from normal
control and affected family members IV-8 and IV-9, by use of primer
pair 3/2. Lanes 1 and 5, Size markers. Lane 2, Unrelated normal
control. Lane 3, Patient IV-8. Lane 4, Patient IV-9. Ampliﬁcation of
the normal control (lane 2) gives the expected single band of 742 bp.
Ampliﬁcation of cDNA from the two patients, IV-8 and IV-9 (lanes
3 and 4, respectively), shows the normal allele of 742 bp and a second
band of 616 bp. The size difference is consistent with the absence of
exon 31. The difference in the intensity of the two bands suggests that
the frequency of exon skipping is õ100%. The numbering of the
exons used here is based on homology to FBN1 and is tentative. b,
DNA sequence analysis of the 616-bp PCR fragment representing the
mutant transcript. The sequence analysis conﬁrms that exon 31 (126
bp) is skipped in one allele of patient IV-8. Identical results were seen
in a similar analysis of cDNA from her affected sibling (patient IV-
9). c, Diagram representing the domain structure of ﬁbrillin-2. The
position of exon 31, which is partially misspliced in this family, is
bracketed. The exon skipping removes one complete calcium-binding
EGF domain.
normal NIRCA patterns. Closer analysis of fragment 3/ sequencing demonstrated that there were no sequence
differences at the ﬂanking splice sites for the patients2 revealed two prominent bands, at 742 bp, correspond-
ing to the expected fragment size, and at 616 bp, consis- compared with normal controls. However, DNA se-
quence analysis revealed a trg transversion at positiontent with a missing exon (ﬁg. 3a). The smaller product
also was detected in cDNA from patient IV-9. DNA 026 of intron 30 (ﬁg. 4). No other alterations were
sequence analysis of the aberrant PCR product revealed
the skipping of exon 31 in both patients (ﬁg. 3b). The
relative intensities of the two bands suggested that the
mutant transcript is misspliced õ100% of the time. The
position of the skipped exon in ﬁbrillin-2 is shown in
ﬁgure 3c. In addition, a faint third band that migrates
just under the 742-bp fragment is present in the affected
individuals but does not amplify out of normal cDNA.
DNA sequence analysis after careful isolation of that
band showed sequence only for the normal allele and
for the mutant transcript described above. It is apparent
from the sequencing that the third band is a hetero-
duplex artifact that forms at high concentrations of the
PCR products.
Figure 4 DNA sequence analysis of genomic DNA from anSplice-Site Analysis
unrelated control individual (left four lanes) and patient IV-8 (right
Splice sites were analyzed by DNA sequence analysis four lanes). The sequence reveals a trg transversion at position 026
of genomic DNA from patients IV-8 and IV-9, to deter- of intron 30 in the patient DNA. The intron-exon boundary between
intron 30 and exon 31 is marked with a horizontal line.mine the cause of the missplicing of exon 31. Exhaustive
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Figure 7 Radioactively labeled PCR ampliﬁcation of cDNA
Figure 5 Diagram of the 3 end of intron 30, showing the posi- from IV-8, by use of primer pair 3/2. Four identical samples were
tion of the t-26g mutation, the putative branch site matching the ampliﬁed, for 18, 20, 22, or 24 cycles; the number of cycles is indicated
branch-point consensus sequence YNYURAY (where YÅ pyrimidine; above the appropriate lane. The autoradiograph shows progressive
N Å any nucleotide; U Å uracil; R Å purine; and A Å the branch- accumulation of product for both the mutant (616 bp) and normal
point adenosine). The proposed branch-point adenosine is marked (742 bp) alleles, with no evidence of any additional bands. The ﬁlm
with an asterisk. PolyPy Å polypyrimidine tract; and 3’ ss Å the 3 was analyzed by densitometry, to estimate the relative amounts of
splice site at the junction between intron 30 and exon 31. each transcript. Analysis of cDNA from patient IV-9 gave comparable
results (data not shown).
found after extensive DNA sequence analysis of addi-
tional ﬂanking intron and exon sequences extending 5
CCA phenotype was demonstrated through three gener-through exon 27 and 3 through exon 42, making it
ations in this family, indicating a causal role in thishighly unlikely that the t-26g alteration is a polymor-
disorder. In addition, the mutant allele was not detectedphism cosegregating on the mutant allele.
in any of the 50 unrelated normal controls, and theIt was noted that intron 30 is unusual in its composi-
normal allele was detected in all individuals analyzedtion, since it has only a very short polypyrimidine tract.
(not shown).Analysis of the intron from 01 through 052, for a po-
tential branch point based on the commonly used con-
Frequency of Exon Skippingsensus sequence YNYURAY (Green 1986; Ohshima and
The ratio between the amount of the normal and mu-Gotoh 1987), shows that the sequence 021 tattgaa 015
tant mRNA species, as determined by coampliﬁcation ofis the best match and therefore the most likely branch
the corresponding cDNAs in the presence of 32PadCTP,point, on the basis of conventional criteria (ﬁg. 5).
indicates that the mutant allele is not always missplicedBlind analysis of genomic DNA from the remaining
(ﬁg. 7). Estimation of the amount of mutant versus nor-family members by allele-speciﬁc PCR ampliﬁcation re-
mal transcript produced by cultured skin ﬁbroblasts de-vealed that the mutation was present in all affected fam-
rived from patients IV-8 and IV-9 indicates that theily members but not in any of the 16 unaffected individu-
mutant transcript constitutes Ç25% of the total mRNAals (ﬁg. 6). Cosegregation of the mutant allele with the
species. This result was consistent in three separate RNA
isolates. The faint third band that, in lanes 3 and 4 of
the PCR ampliﬁcation shown in ﬁgure 3a, is not visible
in these reactions (after£24 cycles of ampliﬁcation) and
apparently does not form until later in ampliﬁcation
(i.e., after 30 cycles), when the products are more con-
centrated.
Figure 6 Example of the allele-speciﬁc PCR analysis of affected
and unaffected family members. The ethidium bromide–stained gel Discussion
shows the results from the analysis of affected and unaffected individu-
als from generation IV and of normal control genomic DNAs. For This study demonstrates, for the ﬁrst time, the cose-
each individual there are two lanes, with PCR products for normal
gregation of a ﬁbrillin-2 mutation with the CCA pheno-and mutant alleles, respectively. The two lanes are indicated by brack-
type. The predominant feature in this family was con-ets, with the individual identiﬁed above. The normal control lanes are
indicated by the ‘‘C.’’ Individuals with two wild-type alleles have a genital ﬂexion contractures that tended to improve with
band in the left lane but no product for the mutant primer in the right age. It is noteworthy that the characteristic external ear
lane. Individuals who are heterozygous for the wild-type and mutant anomalies—cabbage leaf–like auricles—vanished with
alleles have bands in both lanes. Only the affected individuals (IV-5,
increasing age and were inconspicuous in adults. Doli-IV-8, and IV-9) are positive for the mutant allele in the analysis shown
chostenomelia, camptodactyly, arachnodactyly, andhere. All of the living affected family members, along with 16 unaf-
fected family members and 50 unrelated normal controls (not shown), muscle hypoplasia invariably were observed. There is
were tested in a blind study using this analysis. The results are shown no evidence of cardiovascular abnormalities or ectopia
in the pedigree (see ﬁg. 1). All affected individuals are positive for lentis. However, there is considerable intrafamilial vari-
the mutant allele, whereas none of the unaffected family members or
ability. The partial skipping of exon 31, with onlyunrelated normal controls have the mutation. This demonstrates the Ç25% mutant transcript produced, is apparently sufﬁ-cosegregation of the mutant allele with the CCA phenotype through
three generations of this large family. cient to cause the CCA phenotype noted in the proband
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and her brother. It is possible that the phenotypic vari- in this family. It is therefore likely that this mutation,
to some degree, perturbs or destabilizes the natural sec-ability within this family is due to the degree with which
missplicing occurs in a given individual. However, given ondary structure of the transcript, resulting in a partial
disruption of branch formation. Missplicing occursthe two previous reports of mutations associated with
CCA (Putnam et al. 1995; Wang et al. 1996), it appears when the next downstream 3 splice site is utilized as
an alternative. Although we cannot absolutely rule outthat, like Marfan syndrome, there will be considerable
allelic heterogeneity in CCA. a very-low-level use of cryptic splice sites, there is no
evidence for activation of a cryptic splice site.The nature of this particular mutation is especially
interesting. Rather than disrupting a splice-site consen- There has been an ongoing effort to establish phenotype-
genotype correlations between the variable expression ofsus sequence, as is commonly seen with exon skipping,
the mutation is in the region of the splicing branch point, several aspects of the Marfan syndrome phenotype and
FBN1 mutations. These efforts have resulted in the identi-which always occurs 18–37 nucleotides upstream from
the 3 splice site (Green 1986). Examples of mutations ﬁcation of the so-called neonatal region of FBN1, approxi-
mately encompassing exons 23–34. Although defects inin the vicinity of the branch point resulting in exon
skipping are extremely rare (Krawczak et al. 1992) but this region do not result exclusively in the severe neonatal
form of Marfan syndrome, there is a clustering of muta-have been shown to reduce the efﬁciency of correct splic-
ing when they are expressed in vivo as minigenes (Raben tions associated with the early, lethal Marfan phenotype.
Of particular interest, a deletion in exon 31 resulted inet al. 1996; Webb et al. 1996). In addition, this particu-
lar intron is peculiar in that it lacks the lengthy polypyri- neonatal Marfan syndrome (Nijbroek et al. 1995), and a
recurrent missplicing of exon 32 has been seen in twomidine tract that is characteristic of the introns of higher
eukaryotes. The region from 03 to 020 is only 50% unrelated cases of neonatal Marfan syndrome (Wang et
al. 1995). The observation that mutations associated withpyrimidine, as opposed to the ú70% that is characteris-
tic of the introns of higher eukaryotes (Ohshima and the extreme in the Marfan phenotypic spectrum tend to
cluster has driven speculation that this region of the ﬁbril-Gotoh 1987). Likewise, the region from 025 to 030
also is only 50% pyrimidine, whereas ú60% would lin-1 molecule has a critical role in the structure and func-
tion of ﬁbrillin-1 (Putnam et al. 1996). Therefore, it isbe typical. In fact, the longest uninterrupted stretch of
pyrimidines anywhere in the vicinity of the branch point interesting to note that a similar defect in the homologous
region of FBN2, the skipping of exon 31, results in aincludes only six nucleotides. Furthermore, there is an
atypical polyadenosine tract that runs from 09 to 048, relatively mild phenotype with none of the more severe
abnormalities sometimes seen in CCA. In particular, thiswith a base composition of 50% adenosine in that re-
gion. The aberrant composition of intron 30 could play family does not have any of the cardiovascular manifesta-
tions or other unusual malformations occasionally associ-a role in the exon skipping event, since it has been noted
that introns with exceptionally short polypyrimidine ated with CCA (Anderson et al. 1984; Ramos-Arroyo et
al. 1985). Given the large number of affected individualstracts are more likely to be misspliced as the result of a
characterized in this family, this ﬁnding would suggestmutation near the branch point (Krawczak et al. 1992).
that defects in this region of ﬁbrillin-2 do not result inRecent evidence indicates that the length of the polypyri-
a predisposition to either cardiovascular defects or othermidine tract is an important factor in splice-site selection
extreme manifestations of CCA. In addition, the two pre-(Fu¨lo¨p et al. 1996). Also, although there is only a very
viously reported FBN2 missense mutations also were de-weak sequence consensus surrounding branch points in
tected in the exon 23–34 region, with no apparent evi-higher eukaryotes, there is evidence that mutations di-
dence of congenital heart defect or otherwise severerectly upstream from the branch point inﬂuence branch-
phenotypic characteristics being noted in either patientpoint selection and the efﬁciency of accurate splicing
(Putnam et al. 1995). However, there has been a recent(Green 1986). In intron 30, the most likely branch point
report of severe lethal CCA caused by missplicing of exonis 021 tattgaa 015, with the mutation immediately up-
34 (Wang et al. 1996). In this case, the affected childstream at 026 (ﬁg. 5). Although the inﬂuence of the
had complex cardiovascular abnormalities as part of animmediate upstream sequence on branch-point selection
extreme CCA phenotype. The mother had a mild CCAis not known, splice-site choice and splicing efﬁciency
phenotype but was shown to be mosaic for the genomicare inﬂuenced by intramolecular base pairing of the pre-
mutation. This suggests that there may be some domain-mRNA (Goguel and Rosbash 1993). Consequently, loss
speciﬁc functional similarities between ﬁbrillin-1 and ﬁ-of a pyrimidine adjacent to the branch point could be
brillin-2 in the neonatal region—but probably no absolutean important factor here. Finally, cosegregation of the
correlation between the two proteins.mutation with the CCA phenotype in this large kindred,
in conjunction with the absence of any other mutation
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